Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
Indira Turney, an associate research scientist in the Department of Neurology, is studying how lived experiences affect they way the brain ages in diverse populations.
Even in people with complete paralysis after spinal cord injury, some nerves fibers are preserved. A Columbia physician-scientist is developing a new way to salvage those fibers and restore movement.
The Carol and Gene Ludwig Center for Research on Neurodegeneration will bring novel approaches to Alzheimer’s and other neurodegenerative disease research.
Eligible older adults who participate in the Supplemental Nutrition Assistance Program may have slower memory decline than eligible people who do not participate, according to a new study.
In a nationally representative study of cognitive impairment prevalence, Columbia researchers found almost 10% of older adults have dementia and 22% have mild cognitive impairment.
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.